Alendronate Sodium Tablet
Product Images NDC 50090-5677

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 50090-5677). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Alendronate Fig1)

A line graph titled 'Cumulative Incidence of Hip Fractures in the Three-Year Study of FIT' comparing cumulative incidence percentages over 36 months between placebo and Alendronate Sodium groups in patients with radiographic vertebral fracture at baseline. The graph shows lower cumulative incidence for Alendronate Sodium compared to placebo across the study period.*

FDA Label Image

Figure 2 (Alendronate Fig2)

A bar chart titled 'Osteoporosis Treatment Studies in Postmenopausal Women' showing the mean percentage increase in bone mineral density (BMD) at lumbar spine, femoral neck, and trochanter sites after three years of Alendronate 10 mg/day treatment. The chart compares results from U.S. and multinational studies with error bars indicating standard error.*

FDA Label Image

Figure 3 (Alendronate Fig3)

Two line graphs comparing the effect of Alendronate 10 mg versus placebo on lumbar spine bone mineral density (BMD) percent change from baseline over 36 months. The left graph shows results from a U.S. study, and the right graph shows results from a multinational study. In both, Alendronate demonstrates a gradual increase in BMD, while placebo shows no significant change.*

FDA Label Image

Figure 4 (Alendronate Fig4)

A pair of bar charts titled 'Osteoporosis Prevention Studies in Postmenopausal Women' showing the change in bone mineral density (BMD) from baseline over 2-year and 3-year studies. The charts compare BMD percent change for Alendronate 5 mg/day and placebo groups across lumbar spine, femoral neck, trochanter, and total body sites, with Alendronate showing positive changes and placebo showing negative or less positive changes.*

FDA Label Image

Figure 5 (Alendronate Fig5)

Bar chart showing the mean percentage increase in bone mineral density (BMD) relative to placebo plus standard error at one year in glucocorticoid-treated patients taking Alendronate 5 mg/day. The chart compares results between U.S. and multinational groups across three anatomical sites: lumbar spine, femoral neck, and trochanter.*

FDA Label Image

Figure 6 (Alendronate Fig6)

A line chart depicting studies in Paget's Disease of Bone showing the effect on serum alkaline phosphatase with Alendronate 40 mg/day compared to placebo and Etidronate 400 mg/day. The x-axis represents time in months (0, 3, 6), and the y-axis represents mean percent change in serum alkaline phosphatase from baseline. Four lines show values over time for placebo, Etidronate, Alendronate multinational study, and Alendronate U.S. study with corresponding sample sizes for each group indicated.*

FDA Label Image

Chemical Structure (Alendronate Str)

Chemical structure of Alendronate Sodium. The diagram shows the molecular formula with labeled atoms including nitrogen (NH2), carbon chains (CH2), phosphate groups with oxygen and hydroxyl (OH) groups, sodium (Na), and three water molecules (3H2O) associated as a hydrate.*

FDA Label Image

Label Image (Lbl500905677)

Label for Alendronate Sodium 70 mg oral tablets by A-S Medication Solutions, Libertyville, IL. The label includes the NDC 50090-5677-0, product number 6050-0, and instructions to take the medication once weekly. It lists active ingredients including alendronate sodium and references to the sodium and alendronic acid contents. Storage instructions specify keeping it at 68 to 77 degrees Fahrenheit, and the package contains 4 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.